About
PolarityBio develops SkinTE, an investigational autologous multicellular therapy designed to promote healing of chronic wounds including diabetic foot ulcers through cellular regeneration.
Explore PolarityBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.